Abstract. The effects of acrylonitrile (ACN) on human umbilical cord mesenchymal stem cells (hUC-MSCs) remain unknown. The proliferation, differentiation, clonogenicity and apoptosis effects of ACN and/or N-acetyl-L-cysteine (NAC) on hUC-MSCs were investigated. The results showed that although ACN at a concentration of 0.1 µg/ml did not affect proliferation or the morphology of hUC-MSCs compared with the control, osteogenic differentiation and the positive rate of alkaline phosphatase staining in the experimental group were significantly lower compared with the control (P<0.01). All of the effects of ACN were counteracted using NAC, a typical antioxidant. Using a flow cytometry assay, it was observed that ACN induced apoptosis in hUC-MSCs. The results indicated that the toxic effect produced by ACN on hUC-MSCs is based on a redox mechanism.
Introduction
Acrylonitrile (ACN), an industrial nitrile, is a widely used intermediate in the manufacturing of acrylic fibers, plastics, synthetic rubbers, adhesives and pesticides. Potential human exposure to ACN may occur during its production and through the use of ACN-containing products. In clinical applications, ACN is used in the synthesis of biomaterials, including high permeable dialysis tubing (1) and artificial membranes to encapsulate Langerhans islet implants (2) . Furthermore, ACN has been detected in drinking water, cigarette smoke, food and occupational environments (3) (4) (5) . An increase in cancers, mainly of the lung, gastrointestinal and hemopoietic-lymphatic system, in workers occupationally exposed to ACN has been reported (6) . The International Agency for Research on Cancer (IARC) classified ACN as 'possibly carcinogenic to humans' (7).
ACN is acutely toxic to humans. While the America National Institute for Occupational Safety and Health recommended permissible exposure level to ACN is relatively low (1 ppm), high-level exposure may be reached via skin contact in the case of accidental exposure (8) . Studies performed on animals indicated that ACN exhibits mutagenic, embryotoxic (9) , carcinogenic, immunotoxic (10) and hematotoxicity (11) effects. An earlier study demonstrated that blood retains high levels of ACN (12) and indicated a metabolic incorporation and macromolecular interaction of ACN in the liver, spleen, bone marrow, lung and adipose tissues of rats (13) . A previous study also indicated that ACN may interfere with their proliferative activity and with the complex regulation pathways, by modulation of gene and protein expression in hemopoietic cells (14) .
N-acetyl-L-cysteine (NAC) is the acetylated precursor of the amino acid L-cysteine and glutathione (GSH). The biological activity of NAC is attributed to its protection against oxidative and metabolic processes (15) . NAC is a powerful nucleophile capable of scavenging free radicals, stimulating GSH synthesis and enhancing glutathione-S-transferase activity. It has been observed that NAC may prevent ACN-induced damage in glial cells (16) .
Stem cells have been observed to be significant in predicting toxicity by working with in vitro systems (17) and mesenchymal stem cells (MSCs) have attracted more attention due to its multipotency to differentiate into a variety of cell types of mesodermal lineage (18, 19) . In addition, in clinical practice, human umbilical cord MSCs (hUC-MSCs) may be harvested in a safer and more non-invasive manner than bone marrow (BM) and have emerged as a possible alternative cell source to BM-MSCs with less ethical controversy than embryonic stem cells.
There is a lack of information with regard to the potential toxicity of ACN in MSCs. Therefore, the objective of the present study was to investigate the potential cytotoxic effects, as well as the underlying mechanisms of toxicity, induced by ACN in hUC-MSCs.
Materials and methods

Isolation of human umbilical cord cells.
Fresh human umbilical cords were obtained from the Fourth Hospital of Zhenjiang and maintained in sterile conditions at 4˚C. The surface of each cord was rinsed with phosphate-buffered saline (PBS) to remove as much blood as possible and the cord was sliced into 3-5 cm-long sections using sharp, sterile scissors. Blood vessels were removed from each piece of cord then the rest of the tissue was sliced into small fragments ~1 mm 3 . The fragments were seeded onto the surface of a culture dish (with a diameter of 3 cm) with low glucose Dulbecco's modified Eagle's medium (L-DMEM; Gibco-BRL, Carlsbad, CA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS), penicillin (100 U/l) and streptomycin (100 µg/ml) at 37˚C in 5% CO 2 -95% air atmosphere for two weeks. Following two weeks incubation, the explants were removed leaving the cells that had adhered to the plate. When cells grew to 70% confluency, they were harvested and plated onto a 25-cm 2 culture flask. The experimental procedure was approved by Jiangsu University Ethics Committee (Zhenjiang, China) and written informed consent was obtained from the patients.
Cell proliferation and survival assay. The viability and proliferation of cells were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, the cells were plated in 96-well plates and once cells reached 70-80% confluency, the medium was removed and incubated with various concentrations of ACN-dissolved serum-free culture medium for 12 and 24 h, respectively. MTT (20 µl) was added to each well in the final 4 h. The supernatant was discarded and 150 µl dimethyl sulfoxide (DMSO) was added to each well. Following uniform oscillation for 10 min to fully dissolve the crystals, the absorption values were examined using a microplate reader (Biotek, Winooski, VT, USA) with a wavelength of 570 nm.
The hUC-MSCs were plated in 96-well plates and once 70-80% cell confluency was reached, the medium was removed with specific concentrations of NAC serum-free culture medium. After 30 min, 0.1 µg/ml ACN was added to each well. Following 24 h incubation, the viability of the cultured hUM-MSCs was determined by MTT.
Osteogenic differentiation. The multipotent differentiation of the hUC-MSCs was analyzed for osteogenic ability. The cells were inoculated into 24-well plate at 3,000 cells/well in DMEM supplemented with 10% FBS and incubated in a modified version of differentiation medium (containing 4 mg/l basic fibroblast growth factor). The cells were treated for two weeks with osteogenic induction medium (0.1 µM dexamethasone, 10 mM-glycerophosphate, 4 mg/l basic fibroblast growth factor and 50 µg/ml ascorbic acid).
Quantitative polymerase chain reaction (qPCR) assay. Cell lysis and total RNA extraction from control and treated cells treated with ACN using TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) was performed according to the reverse transcription kit instructions (Fermentas, Waltham, MA, USA). The cDNA samples were subjected to PCR using specific primers. The primers were designed and synthesized by Invitrogen Life Technologies according to the serial number from GenBank (Table I ). The reaction was started at 94˚C for 5 min, denaturation at 94˚C for 30 sec, annealing at 55-70˚C for 30 sec and extension for 30 sec at 72˚C followed by 30 cycles and a final polymerization at 72˚C for 10 min. β-actin mRNA was used as an internal control. The products were checked by electrophoresis on a 1.5% agarose gel, with ethidium bromide staining and analyzed using the Gel Image Analysis System (Syngene, Cambridge, UK).
Cytochemical staining. Following hUC-MSC differentiation, osteogenic characteristics were confirmed through alkaline phosphatase (ALP) expression by cytochemical staining. Cells were fixed with 4% paraformaldehyde. The ALP staining kit (Sun Biotech Co., Ltd., Shanghai, China) was used according to the manufacturer's instructions.
Cell cycle assay. hUC-MSCs were treated with ACN and NAC for 24 h. Cells were harvested and washed twice with PBS and stained with propidium iodide (PI; Sigma-Aldrich, St. Louis, MO, USA) for 30 min in dark conditions. The stained cells were analyzed by flow cytometry (FACSCalibur; BD Biosciences, San Diego, CA, USA).
Apoptosis assay. hUC-MSCs were treated with ACN and NAC for 24 h. Following treatment, the cells were trypsinized with 0.25% trypsin-EDTA, washed twice with PBS and stained according to the recommendation of the manufacturer with propidium iodide (PI) and Annexin V-fluorescein isothiocyanate (FITC). The stained cells were analyzed by flow cytometry (FACSCalibur).
Results
Cell morphology and immunological phenotype. hUC-MSCs were observed following an initial three days of primary culture. The cells adhered to plastic surfaces and presented as a small population of single cells with spindle shape. After 7-10 days, the cells appeared as long spindle-shaped fibroblastic cells (Fig. 1) . Following re-plating, the fibroblast-like cells appeared polygonal or spindly, with a long process and were considered normal, on the basis of typical morphology.
Effect of ACN on cell proliferation. To investigate the cytotoxicity of ACN on hUC-MSC proliferation, cells were exposed to specific concentrations of ACN (0, 0.05, 0.1, 0.2,1, 10, 20 and 50 µg/ml) for 12 and 24 h. The MTT assay was used to determine ACN-induced toxicity in hUC-MSC. Following ACN treatment, the activation of hUC-MSC was markedly decreased in a dose-and time-dependent manner (Fig. 2) , indicating that ACN is cytotoxic in hUC-MSC.
Effect of ACN on osteogenic differentiation.
To examine the potential effect of ACN on hUC-MSC to differentiate into osteocytes, the cells were cultured in osteogenic medium. Following 14 days, ALP stain and qPCR was applied for characterization of the osteogenic differentiation. Compared with the control group, the positive rate of ALP was reduced in the ACN group ( Fig. 3A and B; P<0.01). ACN induced a statistically significant difference in the expression of the ALP gene (Fig. 3C) , which is considered to be a marker for osteocytes. These results indicated that ACN inhibits the osteogenic differentiation of MSCs.
Effect of ACN on specific genes of hematogenesis. qPCR was applied for characterization of expression of cytokines in hUC-MSCs, which are important components of the hematopoietic microenvironment, in addition to MSCs. There were dose-dependent decreases in the expression of cytokine vascular endothelial growth factor (VEGF), stem cell factor (SCF) and Fms-like tyrosine kinase 3 (Flt3) showed with treatment of ACN (Fig. 4) . These results indicated that ACN may injure the hematopoietic system by inhibiting the hematopoiesis-supportive function of MSCs.
NAC attenuates ACN-induced cytotoxicity.
Since ACN is capable of inducing oxidative stress, it was investigated whether ACN was capable of inducing oxidative stress in MSCs. Cells were pretreated with an antioxidant, NAC, at different concentrations followed by ACN treatment and cytoactivity was determined. The MTT assay showed that treatment with NAC resulted in a dose-dependent increase in cytoactivity at specific concentrations. The optimal effect was observed at 3 mM, at which point a further increase in NAC did not show any additional benefit (Fig. 5A) . Thus, 3 mM was selected as the concentration of NAC for further studies.
The protection of NAC on ACN-treated cells was further investigated. They all showed significant differences in ACN-treated only groups of concentration 0.05, 0.1, and 0.2 µg/ml, as compared with the corresponding ACN+NAC groups (Fig 5) .
Effect of ACN on cell cycle. Flow cytometry was used to determine whether the inhibitory effect of ACN on MSC proliferation was mediated, at least in part, by affecting cell cycle progression. The results demonstrated that pretreatment with NAC attenuated ACN-induced cell cycle arrest at the G2/M phase and suggested that ACN suppresses cell proliferation by controlling the G2/M checkpoint and inducing a specific block in cell cycle progression (Fig. 6) .
ACN induces cellular apoptosis.
To further study the effect of ACN on hUC-MSC apoptosis, cells were stained with Annexin V/FITC and PI and subsequently analyzed by flow cytometry. Flow cytometric analysis showed that the percentage of hUC-MSCs undergoing apoptosis following ACN-treatment were significantly higher compared with that of the control cells (P<0.01) and the NAC pretreatment group (P<0.05), thus implying that ACN may induce the apoptosis of hUC-MSCs and may be counteracted with the use of NAC (Fig. 7) .
Discussion
There is evidence that the metabolism of ACN to epoxide intermediate 2-cyanoethylene oxide, to form adducts with DNA, may contribute to the toxicity and carcinogenicity of ACN. BM is the site for hematopoiesis to occur, as well as in the cord blood, where there are MSCs that are capable of differentiating into multiple cell types, including adipocytes, chondrocytes, osteocytes and cardiomyocytes (20) . The present study provides evidence that ACN suppresses cytoactivity, differentiation and causes apoptosis in hUM-MSCs. Doses for the current study were selected on the basis of the results of a 24 h in vitro study. ACN (0.1 µg/ml) was observed to affect the proliferation and morphology of MSCs.
The present study demonstrated that ACN disturbed the balance of cell proliferation and induced cell apoptosis, as well as the potential for differentiation. Following osteogenic induction, qPCR analysis of the gene expression of an early marker of cells oriented towards osteogenic production demonstrated downregulation of ALP (21) following ACN treatment, which is an intracellular enzyme required for mineralization. Histological staining supported the qPCR data by demonstrating the presence of ALP positive cells. Therefore, in the present study, ACN exhibited down-regulation of the osteogenic capacity of MSCs.
MSCs produce a number of cytokines and extracellular matrix proteins and express cell adhesion molecules, which are critical for hematopoiesis (22) , thus, the ACN effect on the hematopoiesis by MSCs was investigated. In the present study, 
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qPCR experiments determined mRNA marker expression for a number of the hematopoietic cytokines. VEGF, Flt3 and SCF were downregulated following exposure to ACN. These results indicate that ACN may destroy the hematopoietic microenvironment. It has been reported that ACN was extremely reactive with rat tissue proteins in vivo (23) . Blood was the most reactive tissue studied and hemoglobin was the most reactive protein in blood. MSCs exhibit multilineage differentiation potential and are capable of generating progenitors with restricted developmental potential (24) . In addition, ACN inhibited cell proliferation with a smaller increase in apoptosis. A previous study demonstrated that ACN induces apoptosis (25) and further identified that the mechanism of ACN-induced cell death in hUC-MSCs is through induction of apoptosis involved in the generation of oxidative stress. ACN was observed to cause apoptosis in hUC-MSCs, as was observed by flow cytometry. A number of studies have been published stating that the antioxidant, NAC, protects the rat neurocyte from ACN toxicity, suggesting the involvement of oxidative stress in ACN toxicity. Using NAC as a potential protective agent may induce the apoptosis of hUC-MSCs. Oxidative stress is important in the initiation of apoptosis.
Despite a considerable amount of research, the mechanism directly responsible for ACN toxicity remains unclear. Three distinct pathways have been proposed: i) Reactive oxygen species (ROS) generated as by-products of ACN metabolism via cytochrome P450 2E1 oxidation (26) . ii) Liberation of cyanide from ACN metabolism. Cyanide is a potent generator of ROS production as well as an inhibitor of the activities of several antioxidant enzymes (27, 28) . iii) The process of ACN conjugation with GSH, results in a rapid depletion of GSH and an overall decrease in cellular antioxidant contents. A number of studies have indicated the role of stress in the toxicity of ACN. Esmat et al (29) reported that NAC protects glial cells from ACN toxicity, suggesting the attribution of oxidative stress in ACN toxicity.
In conclusion, ACN may inhibit the proliferation, differentiation and cytokine gene expression of hUC-MSCs and the present study supports the hypothesis that ACN causes apoptosis in hUC-MSCs through a mechanism involving the generation of oxidative stress. We, therefore, require further investigation of the antagonism of antioxidant in these ACN effects.
